艾奧特通訊 ALLT 深 滬
已收盤 02-06 16:00:00 美东时间
9.76
+0.620
+6.78%
華盛通- 最 高9.78
- 今 開9.36
- 成交量 21.70万股
- 最 低 9.21
- 昨 收 9.14
- 總市值 4.73亿
- 52周最高 11.92
- 市盈率 靜 --
- 換手率 0.45%
- 52周最低 4.37
- 委 比 93.26%
- 總股本 4842.56万
- 歷史最高 29.05
- 量 比 0.48
- 振 幅 6.24%
- 歷史最低 1.19
- 每 手 1
- 風險率 1.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
Needham Reiterates Buy on Allot, Maintains $12.5 Price Target
Needham analyst Matthew Calitri reiterates Allot (NASDAQ:ALLT) with a Buy and maintains $12.5 price target.
01-20 19:17
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Cantor Fitzgerald Initiates Coverage On Allot with Overweight Rating, Announces Price Target of $15
Cantor Fitzgerald analyst Jonathan Ruykhaver initiates coverage on Allot (NASDAQ:ALLT) with a Overweight rating and announces Price Target of $15.
01-12 20:36
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
2025-11-24 11:23
Needham Reiterates Buy on Allot, Maintains $12.5 Price Target
Needham analyst Mike Cikos reiterates Allot (NASDAQ:ALLT) with a Buy and maintains $12.5 price target.
2025-11-21 18:42
Allot shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
Allot shares are trading higher after the company reported better-than-expected...
2025-11-20 22:07
Allot Narrows FY2025 Sales Guidance from $98M-$120M to $100M-$103M vs $99.802M Est
Allot (NASDAQ:ALLT) narrows FY2025 sales outlook from $98.000 million-$120.000 million to $100.000 million-$103.000 million vs $99.802 million estimate.
2025-11-20 19:39
Allot Announces Third Quarter 2025 Financial Results
60% YoY SECaaS ARR growth with robust profitability; raising full year guidance HOD HASHARON, Israel, Nov. 20, 2025 /PRNewswire/ -- Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global p...
2025-11-20 19:30
Allot Q3 Adj. EPS $0.10 Beats $0.04 Estimate, Sales $26.405M Beat $25.669M Estimate
Allot (NASDAQ:ALLT) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.04 by 143.9 percent. This is a 233.33 percent increase over earnings of $0.03 per share from the same
2025-11-20 19:22
